This company develops an end-to-end neural platform combining hardware and data analytics to decode and modulate neural networks for treating neurological disorders. Their technology utilizes high-resolution, flexible graphene-based brain-computer interfaces for closed-loop neural decoding and modulation. The platform aims to restore function or mobility for patients through personalized, AI-powered therapy management.
Funding
$73.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
IXFounders
Product
Problem
Current neuroelectronic therapies for neurological disorders are often invasive, offer limited resolution, and provide generic solutions that are not tailored to individual patient needs. These limitations can hinder the effectiveness of treatments aimed at restoring function and mobility.
Solution
INBRAIN Neuroelectronics develops high-resolution, bi-directional brain-computer interfaces (BCIs) using graphene-based technology to decode and modulate neural activity. Their end-to-end neural platform combines hardware and AI-powered data analytics to personalize neuroelectronic therapies, maximizing the time patients spend in therapeutic states and improving functional outcomes. The company's implantable neural processor, coupled with skin-like BCIs featuring up to 1024 contacts, enables real-time smart neural decoding and modulation in closed-loop systems. This approach aims to overcome the limitations of existing neuroelectronic therapies by offering a less invasive and more adaptable solution for patients with conditions like Parkinson's disease.
Target Audience
The primary target audience includes patients with neurological disorders such as Parkinson's disease, as well as clinicians and researchers in the field of neuroelectronics.
Features
- Skin-like, bi-directional, high-resolution (up to 1024 contacts) graphene-based brain-computer interfaces (BCI) for real-time smart neural decoding and modulation.
- Implantable compact neural processor with wireless rechargeable battery, powering signal processing.
- AI-powered platform for therapy personalization, focusing on improving patient outcomes.
- Graphene-based technology enabling high charge injection capacity and low electrical impedance, reducing power requirements and driving miniaturization.
- Patented graphene technology for safe and scalable neural therapies.